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Available online 18 April 2016Global rates of tonsil cancer have been increasing since the turn of themillennia, however we still have a limited
understanding of the genes and pathways which control this disease. This array dataset which is linked to our
publication (Zhang et al., 2015) describes the proﬁling of human miRNAs in tonsil and normal adjacent tissues.
With this dataset, we identiﬁed a list ofmicroRNA (miRNA)whichwere highly over represented in tonsil cancers
and showed that severalmiRNAswere able to regulate the tumour suppressor PDCD4 in a temporal manner. The
dataset has been deposited into Gene Expression Omnibus (GSE75630).
© 2016 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).normal adjacent tissues
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ed for reuse if applicable1. Direct link to deposited data
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE75630.
2. Experimental design, materials and methods
2.1. Patient cohort
The cohort consisted of 43 patients (39 males, 4 females) treated for
tonsillar cancer at Royal Prince Alfred Hospital Sydney, Australia between
2002 and 2006. The mean age was 57 years (range 39–80). Seventeen
Tonsil Squamous Cell Carcinomas (SCCs) and matched microscopically
normal adjacent (2 cm outside the surgical margin) tissues proved suit-
able for the proﬁling analyses (see Fig. 1 for experimental overview).
Sample source location Sydney, Australiagies, Faculty of Engineering and
y, Australia.
en access article under the CC BY-NC2.2. Isolation of RNA from fresh tissue or cultured cells
Approximately 100 mg of fresh frozen tissue was diced and ho-
mogenized with a scalpel blade and then mixed with 1 mL of Trizol
reagent (Invitrogen, USA). Total RNA was then extracted using
isopropanol precipitation and quantiﬁed using a NanoDrop ND
1000 (Thermo Fisher Scientiﬁc, USA). Samples with ratios of 260/
280 in the range of 1.71 to 2.1 were used for the downstream arrays.
2.3. Total RNA labeling
MicroRNAs were labeled at the 3′-end with a P-CU-C3-Cy3 RNA
linker by RNA ligation as described [2,3]. 60 μL ligation reaction
was prepared with 6 μg of total RNA, 0.1 mM ATP, 20 mM MgCl2,
3.5 mM DTT, 10 mg/mL BSA, 10% DMSO, 50 mM HEPES, pH 7.8,
250 ng of P-CU-C3-Cy3 (GeneLink, USA) and 20 units of T4 RNA li-
gase (NEB, USA). The reaction was incubated on ice for 2 h followed
by precipitation at −70 °C for 20 min with 0.3 M sodium acetate,
0.5 mg/mL glycogen (Life Technologies, USA) and 2 volumes of
100% ethanol to remove any unbound RNA-linkers. Each labeled
sample was dissolved in 30 μL of 400-fold diluted ULS labeled refer-
ence set, then mixed with 300 μL Church and Gilbert hybridization
buffer. This mixture was denatured at 95 °C for 2 min before hybrid-
ization. A mixture of 371 synthetic DNA reference oligonucleotides
(Sigma-Genosys, Australia) containing complementary sequences
to all LNA probes, was randomly labeled using the ULYSIS labeling
kit (Invitrogen, USA) and then ﬁltered using a MicroSpin™ G-25
column (Amersham, USA). Aliquots of a 400-fold dilution of labeled
reference set were stored at −20 °C until needed.-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Experimental overviewof the project. Total RNAwas extracted from cancer and normal tissues and themiRNApopulationwas assessed using a custom printed LNA oligonucleotide
array.
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A commercial LNA-modiﬁed oligonucleotides library (Exiqon,
Denmark) based on miRBase release 7.1, covering 371 human andmouse miRNA was utilized for expression proﬁling. Features were de-
posited onto GAPS II slides (Amersham, USA) at a concentration of
10 μM (Australian Genome Research Facility, Australia). Individual
miRNA LNA probes were printed four times on each array. In addition,
Fig. 2. Data processing pipeline using the TM4 suite of tools.
Fig. 3.Unsupervised HCL incorporatingmiRNA signatures from our previous study in salivary g
neck tumours into distinct clusters. Red bars denote tumour tissue, and green bars represent a
95S. Khoury et al. / Genomics Data 8 (2016) 93–96all samples were arrayed in technical duplicate. Pre-hybridization of
array slide was performed in 3× SSC, 0.1% SDS, 0.2% BSA at 60 °C for
1 h. Each slide was then rinsed in full DEPC treated water, followed by
100% ethanol. Hybridizationwas then performed in disposable reaction
chambers (ABGene, USA). The combined hybridization mixture of
330 μL was injected into the chamber, and then incubated in a hybridi-
zation oven with constant rotation at 5 rpm for 3 h at 52 °C. Slides were
then washed brieﬂy in 4× SSC, twice in 2× SSC plus 0.1% SDS, twice in
0.2% SSC and twice in 0.1% SSC. Thesewere then scannedwith a Genepix
4000B Scanner (Axon Instruments, USA). Scanning wavelengths were
set between 600 and 700 for the red channel (wavelength 635) and
500–700 for the green channel (wavelength 532).Measures of intensity
were assigned to each spot on the array using the software GenePix®
Pro Version 5.0 (Axon Instruments, USA).2.5. Microarray data analysis
Raw data manipulation and downstream statistical analyses were
performed using the TM4 suite (http://www.tm4.org) [4]. The ﬁrst
step involved the GenePix Results GPR File conversion using Express
Converter Version 1.7 (Institute for Genomic Research,USA). TheMicro-
arrayData Analysis System (MIDAS) version 2.19 (Institute for Genomic
Research, USA) programwas used to normalise raw experimental array
data [4]. In brief, three types of normalisation were performed. Firstly,
total intensity normalisation was performed, followed by Lowess nor-
malisation and ﬁnally, in-slide replicate normalisation. The Multi-
experimental Viewer (MeV) Version 4.0 (Institute for Genomic Re-
search, USA) program was used to identify genes and expression pat-
terns of interest. Normalised expression data was loaded onto the
program and percentage cut-offs were used to remove genes with inva-
lid expression values, such as buffers. The following operations were
performed on the data to extract gene expression information;land tumours [3] and other oral cancers [1]. HCL was able to separate the various head and
djacent normal tissue.
96 S. Khoury et al. / Genomics Data 8 (2016) 93–96hierarchical clustering, K-means clustering (KMC), t-test and Signiﬁ-
cance Analysis for Microarrays (SAM). Refer to Fig. 2.
3. Discussion
Using this dataset we identiﬁed eleven differentially expressed
miRNAs (N2.0 fold) using the statistical analysis of microarrays
(SAM) algorithm [5]. Of these, nine miRNAs were up-regulated and
two down-regulated in cancers relative to normal tissue. Of particu-
lar note, miR-499, miR-372, miR-18a, miR-21, andmiR-30dwere up-
regulated while let-7c and miR-198 down-regulated. Expression
data for selected miRNAs were then validated using two indepen-
dent patient cohorts which strongly supported the array data. This
analysis was then extended to determine if these tonsil miRNAs sig-
natures could be used as potential diagnostic markers. HCL incorpo-
rating miRNA signatures from the previous study in salivary gland
tumours [3] and other oral cancers was performed. This analysis
was able to deﬁne the different types of head and neck tumoursand cancers (Fig. 3). Clustering was extremely robust, clearly sepa-
rating tumour from normal groups and separating the different
head and neck tumour types.References
[1] X. Zhang, H. Gee, B. Rose, C.S. Lee, J. Clark, M. Elliott, J.R. Gamble, M.J. Cairns, A. Harris,
S. Khoury, et al., Regulation of the tumour suppressor PDCD4 bymiR-499 and miR-21
in oropharyngeal cancers. BMC Cancer 16 (1) (2015) 86.
[2] J.M. Thomson, J. Parker, C.M. Perou, S.M. Hammond, A custom microarray platform
for analysis of microRNA gene expression. Nat. Methods 1 (1) (2004) 47–53.
[3] X. Zhang, M. Cairns, B. Rose, C. O'Brien, K. Shannon, J. Clark, J. Gamble, N. Tran, Alter-
ations in miRNA processing and expression in pleomorphic adenomas of the salivary
gland. Int. J. Cancer 124 (12) (2009) 2855–2863.
[4] A.I. Saeed, V. Sharov, J. White, J. Li, W. Liang, N. Bhagabati, J. Braisted, M. Klapa, T.
Currier, M. Thiagarajan, et al., TM4: a free, open-source system for microarray data
management and analysis. Biotechniques 34 (2) (2003) 374–378.
[5] V.G. Tusher, R. Tibshirani, G. Chu, Signiﬁcance analysis of microarrays applied to the
ionizing radiation response. Proc. Natl. Acad. Sci. U. S. A. 98 (9) (2001) 5116–5121.
